When VKA treatment is interrupted, bridging with unfractionated or low molecular weight heparin is indicated, except in patients with a bileaflet (mechanical) aortic valve replacement and no other risk factors for thrombosis (previous thromboembolism, atrial fibrillation, LVEF < 35%, > 1 mechanical valve— 1).